Peter Hillemanns
Overview
Explore the profile of Peter Hillemanns including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
312
Citations
9856
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kutle I, Polten R, Stalp J, Hachenberg J, Todzey F, Hass R, et al.
Front Immunol
. 2025 Mar;
16:1571555.
PMID: 40061943
[This corrects the article DOI: 10.3389/fimmu.2024.1485461.].
2.
Barth E, Klapdor R, Brodowski L, Hillemanns P, von Kaisenberg C, Dutemeyer V
Arch Gynecol Obstet
. 2025 Feb;
PMID: 39934419
Purpose: To evaluate risk factors in patients presenting with postpartum hemorrhage (PPH) associated with severe blood loss (BL), surgical intervention or peripartum hysterectomy. Methods: This retrospective cohort study included all...
3.
Beckhaus T, Kachuri L, Nakase T, Schurmann P, Eisenblatter R, Geerts M, et al.
J Med Virol
. 2025 Feb;
97(2):e70195.
PMID: 39891432
Infection by high-risk human papillomavirus is known to exacerbate cervical cancer development. The host immune response is crucial in disease regression. Large-scale genetic association studies for cervical cancer have identified...
4.
Kutle I, Polten R, Stalp J, Hachenberg J, Todzey F, Hass R, et al.
Front Immunol
. 2025 Jan;
15:1485461.
PMID: 39781381
Resistance to the currently available treatment paradigms is one of the main factors that contributes to poor outcomes in patients with advanced cervical cancer. Novel targeted therapy approaches might enhance...
5.
Hillemanns P, Zikan M, Forget F, Denys H, Baurain J, Rob L, et al.
J Immunother Cancer
. 2025 Jan;
13(1.
PMID: 39773564
Background: Second-line treatment options for persistent, recurrent or metastatic (r/m) cervical cancer are limited. We investigated the safety, efficacy, and immunogenicity of the therapeutic DNA-based vaccine VB10.16 combined with the...
6.
Maschke S, Steinkasserer L, Renz D, von Kaisenberg C, Hillemanns P, Brodowski L
J Perinat Med
. 2024 Dec;
PMID: 39711256
Objectives: Planning the mode of delivery of a full-term breech singleton remains a challenging task. The aim of this work is to compare the neonatal and maternal short-term outcomes after...
7.
Sayed A, Sayed A, Fard D, Hillemanns P, von Kaisenberg C, Klapdor R
Arch Gynecol Obstet
. 2024 Nov;
PMID: 39601809
Objective: This study aimed to evaluate the effect of maternal active pushing during cesarean section (CS) on postoperative pain, intraoperative discomfort, and the mother's sense of control and participation. Design:...
8.
Kokemuller L, Ramachandran D, Schurmann P, Geffers R, Jentschke M, Bohmer G, et al.
Int J Cancer
. 2024 Oct;
156(4):700-710.
PMID: 39440754
While cervical cancer is associated with a persistent human papillomavirus (HPV) infection, the progression to cancer is influenced by genomic risk factors that have remained largely obscure. Pathogenic variants in...
9.
Stubbe L, Philippeit A, Philippeit J, Kaukemuller L, Kruppa M, Sunder-Plassmann M, et al.
Womens Health Rep (New Rochelle)
. 2024 Oct;
5(1):775-784.
PMID: 39439765
Introduction: High maternal and newborn mortality rates in Sub-Saharan Africa indicate the need for global action interventions. Thus, the clinic cooperation midwife exchange with Uganda (MEWU) between Hannover Medical School...
10.
Zheng Y, Vdovichenko N, Schurmann P, Ramachandran D, Geffers R, Speith L, et al.
Int J Cancer
. 2024 Oct;
156(4):764-775.
PMID: 39400928
Endometrial cancer has been associated with pathogenic variants in mismatch repair (MMR) genes, especially in the context of the hereditary Lynch Syndrome. More recently, pathogenic variants in genes of homology-directed...